Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
A. Enrique Caballero(Beth Israel Deaconess Medical Center), Aristidis Veves(Beth Israel Deaconess Medical Center), Subodh Arora(Beth Israel Deaconess Medical Center), Rola Saouaf(Beth Israel Deaconess Medical Center), Frank W. LoGerfo(Beth Israel Deaconess Medical Center), Edward S. Horton(Joslin Diabetes Center), J Y Park(Beth Israel Deaconess Medical Center), George L. King(Joslin Diabetes Center), Su Chi Lim(National University of Singapore), Paula Smakowski(Beth Israel Deaconess Medical Center)
Cited by 649
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k